font size
Sign in
Todays Stories
Podcast Therapeutic Vaccine for Parkinson's Disease Shows Early Promise

Kuldip Dave, director of research programs for the Michael J. Fox Foundation, discusses encouraging early-stage results for Affiris' experimental therapeutic vaccine for Parkinson's, what the results tell us, and why alpha-synuclein may be a compelling target in the fight against Parkinson’s disease.

By the numbers Pharmas Tap Academia for Drug Discovery



Non-traditional partnering deals have become the norm over the past few years as Big Pharma has shifted its resources away from internal R&D to outsourcing innovation. Such was the case over the past week as Bristol-Myers Squibb and Astellas Pharma partnered to access biopharmaceutical innovation coming out of academia and research institutes.